Meet Dotmatics: Powering Life Sciences Breakthroughs with AI
The International Business Times article highlights how Dotmatics leverages AI-powered software to accelerate research, transform drug discovery, genomics, and data integration, and drive innovation for life sciences organizations across the APAC region.
In this International Business Times feature, IBT highlights how Dotmatics is empowering scientists to accelerate their research and achieve groundbreaking results. Dotmatics is at the forefront of AI-powered solutions, helping life sciences organizations across the APAC region drive innovation and breakthroughs. Their advanced software is transforming drug discovery, genomics research, and data integration, enabling faster, smarter decision-making.
To explore how Dotmatics can help you stay ahead in the rapidly evolving world of life sciences, you can read the full article on the International Business Times website.
Learn More About Dotmatics
Meet with a product expert to discover how Dotmatics' AI-powered software can empower your team to drive innovation in life sciences.
Related
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
U.S. News & World Report: How AI is Transforming Medicine and Patient Care
A U.S. News & World Report article highlights how AI-driven platforms like Dotmatics Luma are revolutionizing healthcare and life sciences by enabling scientists to efficiently manage large datasets, accelerate drug discovery, and enhance patient care through real-time data integration and decision-making.
NBC News: How AI is Transforming Drug Discovery
In an NBC News segment, Alister Campbell, VP of Dotmatics, explains how the company leverages AI to analyze large datasets, predict effective drug compounds, and streamline fragmented data systems and manual workflows, thereby accelerating and improving the efficiency of drug discovery.
Techstrong TV: AI Leadership Insights for Scientific Research and Drug Discovery
In this Techstrong TV interview, Dotmatics CEO Thomas Swalla discusses how the company leverages AI to accelerate scientific research and drug discovery by streamlining workflows, enabling breakthroughs, and reducing costs in R&D.
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
Lessons From The Past Year & My Opportunity to Spend More Time with You
Over the past year since the merger of Dotmatics and Insightful Science, the CEO has focused on building a strong leadership team and strategic acquisitions to enhance customer value, emphasizing the importance of a shared mission over just a shared vision to unify teams and drive purpose-driven work that supports scientific discovery, while acknowledging ongoing integration challenges and the benefits of their chosen M&A approach.